COMPANY PROFILE

Fabentech

Specializes in the development and production of emergency treatments to combat the risks of bioterrorism and emerging infectious diseases that are priorities for public health

Lyon, FranceFounded 2009Biotech & Life Sciences

Valuation $25–50M Last recorded · 2020

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

At a glance

Status: Operational
Founded: 2009
Headquarters: Lyon, France
Employees: 72
Open positions: None listed
Dealroom signal: 79.0/100
Industry: Health
Sub-industry: Pharmaceutical, BioTechnology, Health Platform
Sector: Biotech & Life Sciences, Defence, Biotechnology, Infections and Infectious Diseases, Immune System, Anti-Virus, Biotech and Pharma, Biodefense
Technology: Deep Tech
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

3 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
DEBT✓Debt	Oct 2024	$22M	—	European Investment Bank	↗
LATE VC✓Equity / VC	Feb 2020	$9.3M	$37M	Elaia · Kreaxi · Institut Mérieux · Trail Solutions Patrimoine	↗

Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Year	Margin	Margin
2026	—	—
2025	—	—
2024	—	—
2023	—	—
2022	—	—
2021	—	—
2020	—	—

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Fabentech website traffic

Latest recorded traffic for Fabentech is 1.1K monthly website visits, up 120% over the last three months. Fabentech's team grew 9.1% over the past year.

Latest monthly visits1.1K 3-month web change+120% 1-year team growth+9.1%

Monthly website visitsNov 2017–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
WGWhitelab GenomicsAI platform for accelerating genomic medicine development	Évry-Courcouronnes, France	Operational	54	$11M	$40M
OWOwkinCollaborative research platform and unique AI drug development solutions that make precision medicine a reality	Paris, France	Operational
SUSurgeInnovative fingerprinting of the immune system with AI to holistically improve the perioperative standard-of-care	Paris, France	Operational
QPQubit PharmaceuticalsQuantum physics and AI-driven drug discovery platform	Paris, France	Operational
AQAqemiaUsing quantum-physics with AI to speed up the discovery of novel drug molecules	Paris, France	Operational
IKIktosSpecializing in the development of artificial intelligence solutions applied to chemical research, more specifically medicinal chemistry and new drug design	Paris, France	Operational
VIVitaDXDeveloping a solution for the early detection of bladder cancer	Paris, France	Operational
BIBioSerenityLeading global providers of remote diagnostic solutions	Paris, France	Operational